CN103735690B - 一种治疗胃溃疡的中药及其制备方法 - Google Patents
一种治疗胃溃疡的中药及其制备方法 Download PDFInfo
- Publication number
- CN103735690B CN103735690B CN201410029580.7A CN201410029580A CN103735690B CN 103735690 B CN103735690 B CN 103735690B CN 201410029580 A CN201410029580 A CN 201410029580A CN 103735690 B CN103735690 B CN 103735690B
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- gastric ulcer
- blood
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 208000007107 Stomach Ulcer Diseases 0.000 title claims abstract description 39
- 201000005917 gastric ulcer Diseases 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 210000000952 spleen Anatomy 0.000 claims abstract description 32
- 229940079593 drug Drugs 0.000 claims abstract description 28
- 241000756943 Codonopsis Species 0.000 claims description 23
- 239000009636 Huang Qi Substances 0.000 claims description 12
- 244000132619 red sage Species 0.000 claims description 6
- 241000218176 Corydalis Species 0.000 claims description 4
- 208000027418 Wounds and injury Diseases 0.000 claims description 4
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 claims description 3
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 3
- 241000208340 Araliaceae Species 0.000 abstract description 16
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 16
- 241001619461 Poria <basidiomycete fungus> Species 0.000 abstract description 16
- 235000008434 ginseng Nutrition 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 210000002784 stomach Anatomy 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 7
- 230000008569 process Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 230000007774 longterm Effects 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 230000001476 alcoholic effect Effects 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 239000006187 pill Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 235000014676 Phragmites communis Nutrition 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000007654 immersion Methods 0.000 description 5
- 238000002386 leaching Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000001376 precipitating effect Effects 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 208000008469 Peptic Ulcer Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 238000002575 gastroscopy Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 208000011906 peptic ulcer disease Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010019375 Helicobacter infections Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010017815 Gastric perforation Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000003485 histamine H2 receptor antagonist Substances 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229960003174 lansoprazole Drugs 0.000 description 1
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- OJLOPKGSLYJEMD-URPKTTJQSA-N methyl 7-[(1r,2r,3r)-3-hydroxy-2-[(1e)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate Chemical compound CCCCC(C)(O)C\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC OJLOPKGSLYJEMD-URPKTTJQSA-N 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- 229960005249 misoprostol Drugs 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 210000001711 oxyntic cell Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940126409 proton pump inhibitor Drugs 0.000 description 1
- 239000000612 proton pump inhibitor Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410029580.7A CN103735690B (zh) | 2014-01-22 | 2014-01-22 | 一种治疗胃溃疡的中药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410029580.7A CN103735690B (zh) | 2014-01-22 | 2014-01-22 | 一种治疗胃溃疡的中药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103735690A CN103735690A (zh) | 2014-04-23 |
CN103735690B true CN103735690B (zh) | 2016-02-03 |
Family
ID=50492805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410029580.7A Expired - Fee Related CN103735690B (zh) | 2014-01-22 | 2014-01-22 | 一种治疗胃溃疡的中药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103735690B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138553A (zh) * | 2015-04-01 | 2016-11-23 | 刘大仟 | 一种治疗胃溃疡的中药组合物及其制备方法 |
CN104784651B (zh) * | 2015-05-16 | 2018-01-19 | 张晗 | 一种制备用于治疗胃溃疡的药物制剂的方法 |
CN105214037A (zh) * | 2015-09-30 | 2016-01-06 | 成都恒凌科技有限公司 | 治疗消化性溃疡的固体分散胶囊剂 |
CN105214035A (zh) * | 2015-09-30 | 2016-01-06 | 成都恒凌科技有限公司 | 一种治疗消化性溃疡片剂及其制备方法 |
CN105343800A (zh) * | 2015-12-14 | 2016-02-24 | 陈如燕 | 一种用于治疗胃溃疡的中药制剂及其制备方法 |
CN110327432A (zh) * | 2019-08-14 | 2019-10-15 | 胡世甫 | 一种治疗胃溃疡和糜烂性胃炎的药物及其制备方法 |
CN111358925A (zh) * | 2020-04-09 | 2020-07-03 | 陈益和 | 一种治疗胃炎、胃溃疡制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1895483A (zh) * | 2006-06-28 | 2007-01-17 | 陈江 | 养胃饮料 |
KR101044961B1 (ko) * | 2008-10-14 | 2011-06-29 | 대전대학교 산학협력단 | 황기 및 단삼을 유효성분으로 하는 항암제 부작용 완화용, 항전이 및 항피로 조성물 |
CN101766683B (zh) * | 2008-12-30 | 2012-06-06 | 上海雷允上科技发展有限公司 | 一种丹参分散片及其应用 |
CN103169910A (zh) * | 2011-12-26 | 2013-06-26 | 云南白药集团股份有限公司 | 一种养胃的药物组合物 |
-
2014
- 2014-01-22 CN CN201410029580.7A patent/CN103735690B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103735690A (zh) | 2014-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103735690B (zh) | 一种治疗胃溃疡的中药及其制备方法 | |
CN103316284B (zh) | 一种治疗胆结石的药物 | |
CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
CN105535471A (zh) | 一种用于治疗神经衰弱的丸剂药物及其制备方法 | |
CN101537156A (zh) | 一种治疗胃及十二指肠溃疡病的中草药组合物 | |
CN103182019B (zh) | 治疗复发性口腔溃疡的中药组合物 | |
CN102600426B (zh) | 一种活血化瘀的中药制剂及其制备方法 | |
CN109620899A (zh) | 一种预防或治疗感冒的中药组合物及其制备方法 | |
CN103550696A (zh) | 一种治疗肺癌的药物 | |
CN105535390A (zh) | 一种治疗冠心病的中药汤剂及其制备方法 | |
CN105288351A (zh) | 一种治疗癌症的中药 | |
CN106214986A (zh) | 一种治疗心脑血管疾病的中药汤剂 | |
CN103638426A (zh) | 一种治疗肾虚以及阳痿早泄的中药混合物 | |
CN102973833B (zh) | 一种治疗支气管炎的药物组合物 | |
CN104367984A (zh) | 一种治疗老年冠心病的中药组方 | |
CN105106634A (zh) | 一种治疗急性阑尾炎的中药制剂及其应用 | |
CN103736028A (zh) | 一种治疗口腔扁平苔藓的中药组合物 | |
CN103520426A (zh) | 减轻艾滋病抗病毒药物消化道不良反应的中药 | |
CN102626485A (zh) | 治疗高血压的纯中药制剂 | |
CN102935214A (zh) | 一种治疗尿毒症的中药组合物 | |
CN103263645B (zh) | 一种治疗胃炎、胃溃疡的药物 | |
CN105853872A (zh) | 一种治疗倦怠乏力的新型中药组合物及其制备方法 | |
CN103655846B (zh) | 一种治疗胃络瘀阻证型胃下垂的中药 | |
CN105709005A (zh) | 一种乳康丸 | |
CN104491497A (zh) | 一种治疗神经衰弱的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Guo Changda Inventor after: Guo Qiang Inventor before: Li Xiaobin |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160108 Address after: 230000 Bozhou Industrial Park, Anhui Applicant after: BOZHOU HUQIAO PHARMACEUTICAL Co.,Ltd. Address before: 510006 Panyu District City, Guangzhou Province, the University of Guangdong, West Ring Road, No. 230 Applicant before: Li Xiaobin |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160203 |
|
CF01 | Termination of patent right due to non-payment of annual fee |